Free Trial
NASDAQ:IZTC

Invizyne Technologies (IZTC) Stock Price, News & Analysis

Invizyne Technologies logo
$14.60 -0.55 (-3.60%)
As of 05/22/2025

About Invizyne Technologies Stock (NASDAQ:IZTC)

Key Stats

Today's Range
$14.50
$15.69
50-Day Range
$9.95
$15.63
52-Week Range
$8.50
$23.00
Volume
8,984 shs
Average Volume
37,647 shs
Market Capitalization
$91.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Invizyne Technologies Inc. is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc. is based in Monrovia, CA.

Receive IZTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invizyne Technologies and its competitors with MarketBeat's FREE daily newsletter.

IZTC Stock News Headlines

We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Invizyne announces corporate name change to eXoZymes
Invizyne Technologies Inc trading resumes
Invizyne Technologies Inc trading halted, volatility trading pause
See More Headlines

IZTC Stock Analysis - Frequently Asked Questions

Invizyne Technologies' stock was trading at $16.50 at the start of the year. Since then, IZTC stock has decreased by 11.5% and is now trading at $14.60.
View the best growth stocks for 2025 here
.

Invizyne Technologies (IZTC) raised $15 million in an initial public offering on Wednesday, November 13th 2024. The company issued 1,875,000 shares at a price of $8.00 per share.

Invizyne Technologies' lock-up period expired on Monday, May 12th. Invizyne Technologies had issued 1,875,000 shares in its IPO on November 13th. The total size of the offering was $15,000,000 based on an initial share price of $8.00. Since the expiration of Invizyne Technologies' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

Shares of IZTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IZTC
Previous Symbol
NASDAQ:IZTC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$91.28 million
Optionable
N/A
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:IZTC) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners